Dec 12, 2024, 16:06
Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study
Isabelle Ray-Coquard, Medical Oncologist at Léon Bérard Center, shared a post on LinkedIn, about a paper by her and colleagues, published in Annals of Oncology:
“Paola-1 publications, new episode in Annals of Oncology 2024 revealing that subsequent therapies can be impacted differently after 1st line maintenance with parpi and bevacizumab or bevacizumab alone…
Very proud to share this academic international collaborative new publication from ENGOTov25 Paola-1 study.”
Authors: P. Harter, C. Marth, M. Mouret-Reynier, E. Pujade-Lauraine, I. Ray-Coquard et al.
More posts featuring Isabelle Ray-Coquard.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 12, 2024, 16:06
Dec 12, 2024, 16:00
Dec 12, 2024, 15:54
Dec 12, 2024, 15:49
Dec 12, 2024, 15:45
Dec 12, 2024, 15:42
Dec 12, 2024, 15:40
Dec 12, 2024, 14:54